Lloyd L Tran

Chairman & Chief Scientific Officer · Biomed Industries, Inc · company speakers →

Lloyd is a scientist with 25-year experience in drug development and clinical trials management. He is an inventor with a number of patents in drug therapeutics in the treatment of neurological and metabolic diseases. Lloyd serves as the Chairman & Chief Scientific Officer of Biomed Industries, Inc., the parent company of Biomed Pharmaceuticals, NeuroActiva, Biomed AI and MedAware Systems, Inc. In his early career, he was employed as a research scientist at G.D. Searle, (a subsidiary of Pfizer), and was the director of R&D at Biomed Pharmaceuticals. Lloyd graduated with a BSc (Honours) and completed a PhD in medicinal chemistry at University of Otago and Wellington University of New Zealand.

healthcare-serviceswellness-fitnesspharma-biotech

Is this you? Claim this profile →

No public contact links on file.

Speaking history

World Obesity and Weight Management Congress

23 October 2025 Orlando, United States “NA-931, a novel quadruple IGF-1, GLP-1 and GIP incretin receptor agonist reduces body weight without muscle loss”

International Conference on Neurology and Neurological Disorders

22 June 2026 Barcelona, Spain “Neurogenesis Hypothesis with a Case Study-Phase 2A Clinical Trials of NA-831 for the Treatment of Alzheimer's Disease”

Topics this speaker covers

healthcare-serviceswellness-fitnesspharma-biotech

Sectors

healthcare_medtech_pharma

Sourcing speakers for your event?

Browse the speaker directory →